CN113024538A - 新型吡唑酰胺类化合物及其制备和在防治植物病菌病和杀虫中的应用 - Google Patents

新型吡唑酰胺类化合物及其制备和在防治植物病菌病和杀虫中的应用 Download PDF

Info

Publication number
CN113024538A
CN113024538A CN201911344243.6A CN201911344243A CN113024538A CN 113024538 A CN113024538 A CN 113024538A CN 201911344243 A CN201911344243 A CN 201911344243A CN 113024538 A CN113024538 A CN 113024538A
Authority
CN
China
Prior art keywords
pyrazole
nmr
compounds
novel pyrazole
yield
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201911344243.6A
Other languages
English (en)
Other versions
CN113024538B (zh
Inventor
汪清民
郭金铖
刘玉秀
王兹稳
宋红健
李永强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nankai University
Original Assignee
Nankai University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nankai University filed Critical Nankai University
Priority to CN201911344243.6A priority Critical patent/CN113024538B/zh
Publication of CN113024538A publication Critical patent/CN113024538A/zh
Application granted granted Critical
Publication of CN113024538B publication Critical patent/CN113024538B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/561,2-Diazoles; Hydrogenated 1,2-diazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/74Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
    • A01N43/781,3-Thiazoles; Hydrogenated 1,3-thiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dentistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明涉及新型吡唑酰胺类化合物I及其制备方法和在防治植物病菌病和杀虫中的应用。本发明的新型吡唑酰胺类化合物I在测试浓度为50μg/mL的条件下对14种常见植物病菌都表现了出广谱的离体抗植物病菌活性。Ib‑2、Ib‑6在初筛浓度下对四种被测昆虫幼虫都表现出杀灭活性。

Description

新型吡唑酰胺类化合物及其制备和在防治植物病菌病和杀虫 中的应用
技术领域
本发明涉及含Nortopsentin海洋生物碱活性片段或哌嗪结构的新型吡唑酰胺类化合物及其制备和在防治植物病菌病及杀虫中的应用,属于农业防护技术领域。
背景技术
酰胺类杀菌剂是一类传统的杀菌剂,该类化合物作为杀菌剂已有50多年的历史。而SDHI类杀菌剂无一短缺“酰胺”基团,故最初被称为羧酰胺类杀菌剂。1969年,萎锈灵由有利来路公司(现科聚亚公司)成功开发并上市(Science,1966,152,659-660.),这是该类杀菌剂的第一个商品化的品种。这显然要早于20世纪70年代开发的三唑类杀菌剂,更早于90年代开发的甲氧基丙烯酸酯类杀菌剂。但是直到2009年,琥珀酸脱氢酶抑制剂方自成体系,国际杀菌剂抗性行动委员会(FRAC)在这一年根据作用机理给这类产品单独归类,它们因作用于病原菌线粒体呼吸系统的琥珀酸脱氢酶而正式有了名份,这才从羧酰胺类杀菌剂中脱离出来。
近年来,琥珀酸脱氢酶抑制剂(SDHI)类杀菌剂在杀菌剂市场异军突起。总结下来有两点原因:一方面是之前市场严重依赖那些三唑类(DMI)和甲氧丙烯酸酯(QoI)类杀菌剂,目前已有许多病原菌产生抗药性(FRAC(fungicide resistance action committee),Crop Life.www.frac.info)。另一方面是SDHI类杀菌剂作用机制新颖,不但可用于叶面喷雾,也可作为种子处理剂使用,而且药剂在应用中药效强、作用持久、增产效果显著。不仅对谷类作物均有广谱的抗病效果,而且对一些疾病还能起到一定程度的治疗作用(Proceedings XVI International Plant Protection Congress Glasgow,2007,40-45.)。所以推出新颖SDHI类杀菌剂已成为研究热点之一。
2014年,南开大学赵卫光研究组(Eur.J.Med.Chem.,2014,86,87-94.)合成了一系列新型5-甲基-1H-1,2,3-三唑-4-酰胺衍生物(结构式一),并对其进行了杀菌活性测试。结果表明部分化合物对油菜菌核病菌有很好防效,其中化合物1对该菌的EC50=1.3mg/L。
Figure BSA0000198333390000011
2014年,南京农业大学朱海亮研究组(J.Agric.Food Chem.,2014,62,4063-4071.)基于啶酰菌胺(Boscalid)的分子结构,合成了一系列含有邻位取代的烟酰胺结构的化合物(结构式二)。对其进行了体外菌丝生长抑制试验,结果显示大多数化合物表现出中等活性,其中化合物2的活性最优,对立枯丝核菌(R.solani)和核盘菌(S.sclerotiorum)的IC50值为15.8和20.3μM。
Figure BSA0000198333390000021
2015年,中国农业大学覃兆海研究组(Molecules,2015,20,8395-8408.)合成了一系列新的3-(二氟甲基)-1-甲基-1H-吡唑-4-羧酸酰胺衍生物(结构式三),并对其进行体外菌丝生长抑制试验。从测试结果来看,大多数显示出中等到优秀的活性。对于被测试七种植物病原真菌,其中3m显示出了比啶酰菌胺高的抗真菌活性。
Figure BSA0000198333390000022
2015年,浙江工业大学谭成侠研究组(有机化学,2015,35,422-427.)根据活性亚结构拼接原理,将异噁唑和含氟基团引入到吡唑酰胺结构中,设计了13个未见文献报道的含异噁唑的二氟甲基吡唑酰胺类化合物(结构式四),并对目标产物进行了初步的生物活性测定。结果表明,在剂量为200mg/L时,大部分化合物均表现出较高的杀菌活性。
Figure BSA0000198333390000023
2016年,华中师范大学杨光富研究组(中国科学:化学,2016,46,1188-1194.)通过虚拟筛选得到的先导化合物为起点设计并合成了一系列N-(1-苯胺基-2,2,2-三氯乙基)-1H-吡唑酰胺类化合物(结构式五)。其中化合物4和5对猪心来源SQR的半数有效浓度(IC50)分别达到了0.106μM和15.01nM。之后还进行了分子对接研究,结果表明SDH类抑制剂主要的作用模式是抑制剂分子中羰基与重要的氨基酸残基形成氢键相互作用、抑制剂分子中酸的部分和侧链部分与重要的氨基酸残基形成范德华相互作用。
Figure BSA0000198333390000031
2016年,南京农业大学李圣坤研究组(J.Agric.Food Chem.,2016,64,8927-8934.)合成了一系列结构新颖的含噁唑的烟酰胺衍生物(结构式六),并考察了其杀菌活性,结果表明,化合物6对水稻纹枯病菌、灰霉病菌和油菜菌核病菌EC50分别为0.58mg/L、0.42mg/L和2.10mg/L,表现出了较好的抑菌活性。分子对接研究表明SDH的Trp-173位点与分子噁唑环的氮元素间存在氢键,并且研究指出不同构象的分子和靶标间的成键元素不同,例如该化合物的S构象,与Trp-173位点形成氢键的是噁唑环的氧元素而非氮元素。
Figure BSA0000198333390000032
2017年,安徽农业大学曹海群研究组(Pest Manag.Sci.,2017,73,1585-1592.)合成了一系列新型含吡唑的吡啶酰胺类化合物(结构式七),并对其进行了抗菌活性测试。结果显示化合物7对玉米小斑病菌、小麦纹枯病菌EC50分别为33.5mg/L和21.4mg/L。分子对接表明该化合物与SDH的Arg-43、Tyr-58位点存在π键作用,和Trp-173位点存在氢键作用。
Figure BSA0000198333390000033
2017年,华中师范大学杨光富研究组(J.Agric.Food Chem.,2017,65,1021-1029.)合成了一系列含二苯醚结构的吡唑酰胺类SDHI类杀菌剂(结构式八)。测试结果表明,大部分化合物都表现出了良好的SQR抑制活性以及在200mg/L的剂量下对立枯丝核菌(Rhizoctonia solani)和白粉菌(Sphaerotheca fuliginea)具有良好的杀菌活性。其中化合物8的抑制常数(Ki)为0.081μM,是吡噻菌胺(Penthiopyrad)的四分之一。
Figure BSA0000198333390000041
2017年,四川大学侯太平研究组(Chin.Chem.Lett.,2017,28,1731-1736.)设计合成了27个含有二苯胺结构的吡唑酰胺类衍生物(结构式九)。生测结果表明,部分化合物对立枯丝核菌、禾谷丝核菌以及核盘菌有较好的抑制活性,尤其是化合物9。其对立枯丝核菌、禾谷丝核菌以及核盘菌的体外抑制半数有效浓度(IC50)分别为0.013、1.608和1.874μg/mL,对立枯丝核菌的体内抑制半数有效浓度(IC50)也达到22.21mg/mL。分子对接表明该化合物与SDH的Trp-73、Phe-64位点存在π-π相互作用。
Figure BSA0000198333390000042
同年,该研究组(Bioorg.Med.Chem.Lett.,2017,27,90-93.)以啶酰菌胺(Boscalid)与氟唑菌酰胺(Fluxapyroxad)为先导,设计并合成了一系列结构新颖的呋喃酰胺类SDHI类杀菌剂(结构式十)。杀菌活性测试表明,化合物10对水稻纹枯病菌EC50为0.037mg/L,具有很好防效。分子对接研究表明,该分子的2-甲基呋喃部分作用在了SDH的B/Pro-202,B/Ile-251,C/Ile-77和C/Trp-73组成的疏水腔中。
Figure BSA0000198333390000043
2018年,南京农业大学李圣坤研究组(J.Agric.Food Chem.,2018,66,8957-8965.)在2016年工作(J.Agric.Food Chem.,2016,64,8927-8934.)的基础上,将研究重心转移到优化极性部分,又设计并合成了一系列的含有2-(2-噁唑啉基)苯胺结构的手型SDHI类杀菌剂(结构式十一)。生物测试结果表明,其中化合物11在50mg/L浓度下对灰霉菌的抑制率达到93.9%。
Figure BSA0000198333390000051
Nortopsentin类生物碱是一类从海洋生物中发现并分离得到的天然产物(结构式十二)。2018至2019年,汪清民课题组发现该类生物碱及其衍生物具有一定的杀菌活性(J.Agric.Food Chem.,2018,66,4062-4072.;J.Agric.Food Chem.,2019,67,10018-10031.)。
Figure BSA0000198333390000052
自2003年啶酰菌胺成功上市之后,SDHI类杀菌剂由于其广谱、高效的杀菌活性及无交互抗性等特点,已经成为市场上一类非常重要的杀菌剂品种。虽然近些年新颖的SDHI类杀菌剂层出不穷,但仍需要进行结构的拓展和构效关系的研究。
发明内容
本发明提供含Nortopsentin海洋生物碱活性片段或哌嗪结构的新型吡唑酰胺类化合物I及其制备方法和在防治植物病菌病和杀虫中的应用。本专利的含Nortopsentin海洋生物碱活性片段或哌嗪结构的新型吡唑酰胺类化合物I具有很好的抗植物病菌活性。通式I包含Ia和Ib两种结构类型,具体为化合物Ia-1~Ia-4和Ib-1~Ib-9所示的化合物。
Figure BSA0000198333390000053
Figure BSA0000198333390000061
Ia-1~Ia-4按照反应式一所示的方法制备:使用已商品化的3-(二氟甲基)-1-甲基-1H-吡唑-4-羧酸为原料在氯化亚砜中加热回流制得吡唑酰氯。随后再用吡唑酰氯和相应的Nortopsentin噻唑类衍生物在四丁基硫酸氢铵做相转移催化剂、氢氧化钠做缚酸剂条件下进行酰化反应得到目标化合物Ia-1~Ia-4。
Figure BSA0000198333390000062
Ib-1~Ib-9按照反应式二所示的方法制备:使用邻硝基对三氟甲基氟苯与吗啉或单取代的哌嗪进行亲核取代得到相应的中间体a-1~a-9。利用钯碳和氢气体系还原硝基到氨基。最后与吡唑酰氯发生酰化反应得到目标化合物Ib-1~Ib-9。
Figure BSA0000198333390000071
本发明的新型吡唑酰胺类化合物I表现出很好的抗植物病菌活性和杀虫活性,能很好地抑制黄瓜枯萎,花生褐斑,苹果轮纹,小麦纹枯,玉米小斑,西瓜炭疽,水稻恶苗,番茄早疫,小麦赤霉,马铃薯晚疫,辣椒疫霉,油菜菌核,黄瓜灰霉,水稻纹枯14种植物病菌。
具体实施方式
下述的实施例和生测试验结果可用来进一步说明本发明,但不意味着限制本发明。
实施例1:3-(二氟甲基)-1-甲基-1H-吡唑-4-羰基氯的合成
取100mL单口瓶加入3-(二氟甲基)-1-甲基-1H-吡唑-4-羧酸(3.52g,20mmol)以及10mL氯化亚砜,加热回流,约3h反应完,可看到固体慢慢溶解,脱溶后得到黄色液体3.88g,收率:99%。1H NMR(400MHz,CDCl3)δ8.08(s,1H),6.93(t,J=53.4Hz,1H),4.02(s,3H).
实施例2:新型吡唑酰胺类化合物Ia-1~Ia-4的合成
Ia-1的合成:取100mL单口瓶,将3-(二氟甲基)-1-甲基-1H-吡唑-4-羰基氯(0.57g,1.6mmol)以及四丁基硫酸氢铵(0.005g,0.1%mmol)溶于10mL二氯甲烷,再加入氢氧化钠粉末(0.16g,4.1mmol),将溶有Nortopsentin噻唑类衍生物(0.47g,2.5mmol)的5mL二氯甲烷溶液逐滴加入到上述溶液中,室温搅拌,TLC监测,大约1h反应完毕。将反应后得溶液倒入水中,用乙酸乙酯萃取,无水硫酸钠干燥,脱溶,白色固体0.73g,收率:89%,熔点:206-208℃。1H NMR(400MHz,DMSO-d6)δ8.65(s,1H),8.58(s,1H),8.42(d,J=8.5Hz,1H),8.38(s,1H),8.27(s,1H),8.09(d,J=7.6Hz,2H),7.65(d,J=8.5Hz,1H),7.61-7.52(m,3H),7.26(t,J=54Hz,1H),4.04(s,3H).13C NMR(100MHz,CDCl3)δ167.4,161.4,149.3,146.6(t,J=25.6Hz),137.0,136.5,133.3,130.9,129.8,127.6,126.7,123.7,119.0,118.4,116.6,115.8,113.7,110.4(t,J=234.9Hz).C23H16BrF2N4OS[M+H]+513.0191,found(ESI+)513.0188.
化合物Ia-2,Ia-3,Ia-4的合成参照化合物Ia-1的合成方法,原料为相应原料
Ia-2:白色固体,收率:73%,熔点:110-112℃。1H NMR(400MHz,CDCl3)δ8.68(s,1H),7.89-7.85(m,3H),7.49(d,J=8.2Hz,1H),7.36(s,1H),7.04(t,J=54.0Hz,1H),4.04(s,3H),3.05(t,J=7.7Hz,2H),1.90-1.76(m,2H),1.49-1.42(m,2H),1.39-1.28(m,4H),0.91(t,J=6.2Hz,3H).13C NMR(100MHz,CDCl3)δ171.8,160.7,147.3(t,J=7.1Hz),137.1,133.5,127.7,127.2,124.7,121.6,119.7,119.3,117.9,114.7(t,J=2.2Hz),113.2,109.6(t,J=237.7Hz),40.0,33.6,31.5,30.1,28.8,22.6,14.1.C23H24BrF2N4OS[M+H]+521.0817,found(ESI+)521.0816.
Ia-3:白色固体,收率:93%,熔点:208-209℃。1H NMR(400MHz,DMSO-d6)δ8.60(s,1H),8.55(d,J=1.3Hz,1H),8.27(d,J=8.5Hz,1H),8.20(s,1H),8.01(s,1H),7.60(dd,J=8.5,1.6Hz,1H),7.23(t,J=54Hz,1H),4.02(s,3H),2.76(s,3H).13C NMR(100MHz,CDCl3)δ165.9,161.4,147.6,146.5(t,J=24.8Hz),138.8,136.9,136.2,127.5,127.4,126.2,123.5,119.0,118.4,116.9,115.0,113.7,110.4(t,J=235.1Hz),19.3.C23H14BrF2N4OS[M+H]+451.0034,found(ESI+)451.0035.
Ia-4:白色固体,收率:84%,熔点:117-119℃。1H NMR(400MHz,DMSO-d6)δ8.58(d,J=25.6Hz,2H),8.30(d,J=7.3Hz,1H),8.24(s,1H),8.02(s,1H),7.60(d,J=6.9Hz,1H),7.23(t,J=54Hz,1H),4.02(s,3H),1.47(s,9H).13C NMR(100MHz,CDCl3)δ180.7,161.4,147.5,146.5(t,J=5.0Hz),138.9,136.9,136.5,127.9,127.5,126.1,123.8,118.9,118.3,117.0,114.3,113.8,110.4(t,J=235.0Hz),37.8,31.1.C21H20BrF2N4OS[M+H]+493.0504,found(ESI+)493.0509.
实施例3:中间体a-1~a-9的合成
a-1的合成:取100mL单口瓶,加入K2CO3(1.03g,7.5mmol)和10mL DMF,之后分别将吗啉(0.45mL,5mmol)和4-氟-3-硝基三氟甲苯(0.70mL,5mmol)溶于其中,加热至90℃反应。TLC监测,大约3h反应完毕。减压蒸馏,脱去DMF,将所得粗产品加入水中,用DCM(3×20mL)萃取,饱和食盐水洗涤,无水硫酸钠干燥,脱溶后得黄色液体1.34g,收率97%。1H NMR(400MHz,CDCl3)δ8.07(d,J=1.6Hz,1H),7.70(dd,J=8.7,1.9Hz,1H),7.18(d,J=8.7Hz,1H),3.86(t,J=4.6Hz,4H),3.15(t,J=4.6Hz,4H).
化合物a-2~a-9的合成参照化合物a-1的合成方法,原料为相应原料
a-2:黄色液体,收率:96%。1H NMR(400MHz,DMSO)δ8.14(s,1H),7.85(d,J=8.6Hz,1H),7.44(d,J=8.8Hz,1H),3.13(s,4H),2.42(s,4H),2.22(s,3H).
a-3:黄色液体,收率:96%。1H NMR(400MHz,CDCl3)δ8.08(d,J=1.2Hz,1H),7.69(dd,J=8.7,1.7Hz,1H),7.18(d,J=8.7Hz,1H),3.61(s,4H),3.13(s,4H),1.48(s,9H).
a-4:黄色液体,收率:96%。1H NMR(400MHz,CDCl3)δ8.03(d,J=1.3Hz,1H),7.65(dd,J=8.8Hz,1.9Hz,1H),7.15(d,J=8.8Hz,1H),3.17(t,J=4.8Hz,4H),2.76-2.70(t,J=4.8Hz,4H),1.10(s,9H).
a-5:黄色液体,收率:99%。1H NMR(400MHz,CDCl3)δ8.09(s,1H),7.70(dd,J=8.7,1.6Hz,1H),7.30(t,J=8.0Hz,2H),7.22(d,J=8.7Hz,1H),6.96(d,J=7.9Hz,2H),6.92(t,J=7.3Hz,1H),3.35(d,J=3.7Hz,8H).
a-6:黄色液体,收率:81%。1H NMR(400MHz,CDCl3)δ8.04(d,J=1.1Hz,1H),7.65(dd,J=8.8,1.8Hz,1H),7.37-7.27(m,5H),7.14(d,J=8.8Hz,1H),3.58(s,2H),3.17(t,J=4.8Hz,4H),2.60(t,J=4.8Hz,4H).
a-7:黄色液体,收率:99%。1H NMR(400MHz,CDCl3)δ8.11(d,J=1.6Hz,1H),7.72(dd,J=8.7,2.0Hz,1H),7.19(d,J=8.7Hz,1H),3.85-3.77(m,2H),3.70-3.62(m,2H),3.19-3.14(m,4H),2.15(s,3H).
a-8:黄色固体,收率:99%。熔点:56-57℃。1H NMR(400MHz,CDCl3)δ8.09(d,J=1.6Hz,1H),7.71(dd,J=8.7,2.0Hz,1H),7.38(d,J=9.0Hz,2H),7.22(d,J=8.7Hz,1H),6.82(d,J=9.0Hz,2H),3.32(s,8H).
a-9:黄色液体,收率:99%。1H NMR(400MHz,CDCl3)δ8.04(d,J=1.3Hz,1H),7.65(dd,J=8.8,1.9Hz,1H),7.16(d,J=8.8Hz,1H),3.18(t,J=4.8Hz,4H),2.60(t,J=4.8Hz,4H),2.44-2.41(t,J=7.6Hz,2H),1.54-1.46(m,2H),1.40-1.29(m,2H),0.93(t,J=7.3Hz,3H).
实施例4:中间体b-1的合成
b-1的合成:在100mL的单口瓶中,将化合物a-1(0.64g,2.3mmol)溶于10mL甲醇中,加热至回流,再加入5%的钯碳,随后逐滴加入1.7mL 80%的水合肼。TLC监测,大约10h反应完毕。将反应完的溶液过滤,取滤液进行硅胶柱层析(PE∶EA=10∶1),得到红色液体0.43g,收率:76%。1H NMR(400MHz,DMSO)δ7.01(d,J=8.1Hz,1H),6.97(d,J=2.0Hz,1H),6.84(dd,J=8.1,1.4Hz,1H),5.20(s,2H),3.81-3.72(m,4H),2.88-2.78(m,4H).
实施例5:中间体b-2~b-9的合成
b-2的合成:在100mL四口瓶中加入化合物a-2(0.29g,1mmol)和10%的钯碳以及10mL的甲醇,通入氢气,在室温下反应。TLC监测,大约1h反应完。将反应完的反应液进行抽滤,滤液减压蒸馏,得无色液体0.16g,收率:82%。1H NMR(400MHz,DMSO)δ7.02(d,J=8.1Hz,1H),6.98(d,J=1.8Hz,1H),6.85(dd,J=8.2,1.1Hz,1H),5.10(s,2H),2.85(s,4H),2.47(s,4H),2.24(s,3H).
化合物b-3~b-9的合成参照化合物b-1的合成方法,原料为相应原料
b-3:无色液体,收率:94%。1H NMR(400MHz,CDCl3)δ7.02(s,2H),6.98(s,1H),4.12(s,2H),3.61(s,4H),2.90(s,4H),1.52(s,9H).
b-4:无色液体,收率:78%。1H NMR(400MHz,CDCl3)δ7.04(d,J=8.2Hz,1H),6.98(dd,J=8.0,1.6Hz,1H),6.93(d,J=1.7Hz,1H),4.07(s,2H),2.96(s,4H),2.74(s,4H),1.12(s,9H).
b-5:无色液体,收率:82%。1H NMR(400MHz,CDCl3)δ7.30(d,J=1.3Hz,2H),7.07(s,1H),7.04-6.96(m,4H),6.90(s,1H),4.11(s,2H),3.35(s,4H),3.10(t,J=4.8Hz,4H).
b-6:无色液体,收率:75%。1H NMR(400MHz,CDCl3)δ7.36-7.29(m,4H),7.26(d,J=6.6Hz,1H),6.99(d,J=8.3Hz,1H),6.96(dd,J=8.4,1.5Hz,1H),6.89(d,J=1.6Hz,1H),4.02(s,2H),3.56(s,2H),2.93(t,J=4.0Hz,4H),2.62(s,4H).
b-7:无色液体,收率:81%。1H NMR(400MHz,CDCl3)δ7.02(s,2H),6.99(s,1H),4.14(s,2H),3.88-3.60(m,4H),2.99-2.89(m,4H),2.18(s,3H).
b-8:白色固体,收率:82%。1H NMR(400MHz,CDCl3)δ7.38(d,J=8.8Hz,1H),7.07(d,J=8.2Hz,1H),7.01(d,J=8.4Hz,1H),6.97(s,1H),6.85(d,J=8.8Hz,1H),3.31(s,4H),3.09(t,J=4.4Hz,4H).
b-9:无色液体,收率:90%。1H NMR(400MHz,CDCl3)δ7.07(d,J=8.2Hz,1H),7.01(dd,J=8.4,0.8Hz,1H),6.97(s,1H),4.09(s,2H),3.00(s,4H),2.64(s,2H),2.47-2.39(m,2H),1.55(ddd,J=15.3,8.7,6.3Hz,2H),1.44-1.33(m,2H),0.97(t,J=7.3Hz,3H).
实施例6:新型吡唑酰胺类化合物Ib-1~Ib-9的合成
Ib-1的合成:在100mL的单口瓶中,将化合物b-1(0.43g,1.7mmol)和三乙胺(0.42mL,2.1mmol)溶于15mL的DCM,冰浴下滴加3-(二氟甲基)-1-甲基-1H-吡唑-4-羰基氯的DCM溶液。滴加完毕后移至室温下反应。TLC监测,大约30min反应完毕。硅胶柱层析,得白色固体0.67g,收率97%。熔点:203-204℃。1H NMR(400MHz,CDCl3)δ9.29(s,1H),8.81(s,1H),8.04(s,1H),7.38(dd,J=8.0,1.2Hz,1H),7.32(d,J=8.3Hz,1H),6.92(t,J=54.1Hz,1H),3.99(s,3H),3.87(t,J=4.4Hz,4H),2.89(t,J=4.4Hz,4H).13C NMR(100MHz,CDCl3)δ159.5,144.6,142.6(t,J=29.2Hz),136.0,134.3,127.8(q,J=32.3Hz),124.0(q,J=270.7Hz),121.5,121.08(q,J=3.9Hz),117.73(q,J=3.8Hz),117.1,111.7(t,J=233.3Hz),66.8,52.6,39.6.C17H18F5N4O2[M+H]+405.1344,found(ESI+)405.1345.
化合物Ib-2~Ib-9的合成参照化合物Ib-1的合成方法,原料为相应原料
Ib-2:白色固体,收率95%。熔点:194-196℃。1H NMR(400MHz,DMSO-d6)δ9.27(s,1H),8.51(s,1H),8.20(s,1H),7.48(s,1H),7.38(t,J=67.2Hz,1H),7.35(d,J=4.8Hz,1H),4.00(s,3H),2.92(s,4H),2.51(s,5H),2.24(s,3H).13C NMR(100MHz,CDCl3)δ159.6,144.9,143.3(t,J=28.3Hz),135.0,134.0,127.4(q,J=32.2Hz),124.0(q,J=270.5Hz),121.3,121.01(q,J=4.0Hz),117.39(q,J=4.0Hz),117.1,111.2(t,J=234.1Hz),55.1,52.2,46.1,39.7.C18H21F5N5O[M+H]+418.1661,found(ESI+)418.1660.
Ib-3:白色固体,收率95%。熔点:133-134℃。1H NMR(400MHz,CDCl3)δ9.29(s,1H),8.82(s,1H),8.06(s,1H),7.39(d,J=7.9Hz,1H),7.30(d,J=6.2Hz,1H),6.93(t,J=54.1Hz,1H),4.01(s,3H),3.62(s,4H),2.86(s,4H),1.51(s,9H).13C NMR(100MHz,CDCl3)δ159.6,154.7,144.7,142.7(t,J=28.9Hz),135.9,134.3,127.9(q,J=32.7Hz),124.0(q,J=272.2Hz),121.5,121.0(q,J=3.6Hz),117.7(q,J=3.9Hz),117.0,111.7(t,J=233.5Hz),80.1,52.3,39.6,28.4.C22H27F5N5O3[M+H]+504.2029,found(ESI+)504.2025.
Ib-4:白色固体,收率:86%。熔点:181-182℃。1H NMR(400MHz,DMSO-d6)δ9.28(s,1H),8.50(s,1H),8.19(d,J=1.8Hz,1H),7.48(dd,J=8.8,2.1Hz,1H),7.37(d,J=8.4Hz,1H),7.33(t,J=67.2Hz,1H),3.98(s,3H),2.91(t,J=4.4Hz,4H),2.68(s,4H),1.05(s,9H).13C NMR(100MHz,CDCl3)δ159.5,145.0,143.3(t,J=28.3Hz),135.1,134.0,127.3(q,J=32.2Hz),124.07(q,J=272.2Hz),121.30(s),121.02(q,J=3.7Hz),117.31(q,J=3.7Hz),117.2,111.2(t,J=234.3Hz),52.9,45.7,39.7,25.8.C21H27F5N5O[M+H]+460.2130,found(ESI+)460.2131.
Ib-5:白色固体,收率:82%。熔点:201-203℃。1H NMR(400MHz,DMSO-d6)δ9.36(s,1H),8.53(s,1H),8.27(s,1H),7.53(dd,J=8.4,1.7Hz,1H),7.44(d,J=8.4Hz,1H),7.36(t,J=67.2Hz,1H),7.28-7.21(m,2H),7.00(d,J=8.1Hz,2H),6.80(t,J=7.2Hz,1H),3.96(s,3H),3.39-3.34(m,4H),3.14-3.04(m,4H).13C NMR(100MHz,CDCl3)δ159.6,151.1,144.8,143.1(t,J=28.5Hz),135.3,134.2,129.3,127.7(q,J=32.6Hz),124.0(q,J=272.1Hz),121.3,121.1(q,J=3.8Hz),120.2,117.6(q,J=4.0Hz),117.1,116.2,111.4(t,J=233.9Hz),52.4,49.3,39.7.C23H23F5N5O[M+H]+480.1817,found(ESI+)480.1815.
Ib-6:白色固体,收率:30%。熔点:133-134℃。1H NMR(400MHz,CDCl3)δ9.16(s,1H),8.74(s,1H),7.96(s,1H),7.40-7.27(m,7H),6.97(t,J=54.1Hz,1H),3.98(s,3H),3.60(s,2H),2.92(t,J=4.4Hz,4H),2.63(s,4H).13C NMR(100MHz,CDCl3)δ159.6,145.0,143.4(t,J=27.7Hz),137.8,134.9,134.0,129.2,128.3,127.3(q,J=32.4Hz),127.2,124.1(q,J=272.1Hz),121.3,121.0(q,J=4.0Hz),117.4(q,J=4.0Hz),117.1,111.1(t,J=234.2Hz),63.0,53.0,52.3,39.7.C21H27F5N5O[M+H]+494.1974,found(ESI+)494.1980.
Ib-7:白色固体,收率:84%。熔点:158-159℃。1H NMR(400MHz,DMSO-d6)δ9.37(s,1H),8.53(s,1H),8.32(d,J=1.7Hz,1H),7.51(dd,J=7.6,1.6Hz,1H),7.40(d,J=8.4Hz,1H),7.36(t,J=67.2Hz,1H),4.00(s,3H),3.65(s,4H),3.35(s,1H),2.94-2.84(m,4H),2.05(s,3H).13C NMR(100MHz,CDCl3)δ169.2,159.6,144.2,142.3(t,J=29.3Hz),136.4,134.4,128.0(q,J=32.6Hz),124.0(q,J=272.1Hz),121.6,121.1(q,J=3.8Hz),117.7(q,J=4.0Hz),116.9,111.9(t,J=233.0Hz),52.5,52.2,46.1,41.2,39.6,21.3.C19H21F5N5O2[M+H]+446.1610,found(ESI+)446.1606.
Ib-8:白色固体,收率:80%。熔点:234-235℃。1H NMR(400MHz,DMSO-d6)δ9.36(s,1H),8.53(s,1H),8.27(d,J=1.6Hz,1H),7.53(dd,J=8.5,1.6Hz,1H),7.43(d,J=8.4Hz,1H),7.37(d,J=9.0Hz,2H),7.36(t,J=67.2Hz,1H),6.96(d,J=9.0Hz,2H),3.97(s,3H),3.35(s,4H),3.06(s,4H).13C NMR(100MHz,DMSO-d6)δ160.3,150.4,147.7,145.2(t,J=23.9Hz),133.9,132.5,132.0,124.7(q,J=271.8Hz),124.4(q,J=32.1Hz),122.3(q,J=3.5Hz),121.4,120.2(q,J=3.8Hz),117.8,116.1,110.6,110.5(t,J=234.3Hz),51.2,48.3.C23H22BrF5N5O[M+H]+558.0922,found(ESI+)558.0920.
Ib-9:白色固体,收率:88%。熔点:200-201℃。1H NMR(400MHz,DMSO)δ9.38(s,1H),8.74(s,1H),8.29(d,J=1.7Hz,1H),7.54(dd,J=8.5,1.7Hz,1H),7.41(d,J=8.4Hz,1H),7.36(t,J=67.2Hz,1H),4.01(s,3H),3.55(s,2H),3.27(s,6H),3.17-3.12(m,2H),1.80-1.65(m,2H),1.42-130(m,2H),0.93(t,J=7.4Hz,3H).13C NMR(100MHz,CDCl3)δ159.3,142.6,141.2(t,J=29.8Hz),137.5,134.6,129.0(q,J=32.6Hz),123.8(q,J=272.6Hz),122.7,121.2(q,J=3.8Hz),117.7(q,J=4.0Hz),116.7,112.7(t,J=232.0Hz),57.4,51.7,49.1,39.7,25.4,20.1,13.5.C21H27F5N5O[M+H]+460.2130,found(ESI+)460.2133.
实施例7:抗菌活性测试,测定程序如下:
离体杀菌测试,菌体生长速率测定法(平皿法):
将一定量药剂溶解在适量丙酮内,然后用含有200ug/mL乳化剂水溶液稀释至所需浓度,然后各吸取1mL药液注入培养皿内,再分别加入9mL培养基,摇匀后制成50ug/mL的含药平板,以添加1mL灭菌水的平板做空白对照。用直径4mm的打孔器沿菌丝外缘切取菌盘,移至含药平板上。每处理重复三次。将培养皿放在24±1℃恒温培养箱内培养。48小时后调查各处理菌盘扩展直径,求平均值,与空白对照比较计算相对抑菌率。
Figure BSA0000198333390000121
表1新型吡唑酰胺类化合物Ia-1~Ia-4和Ib-1~Ib-9的离体抗植物病菌活性测试结果:
Figure BSA0000198333390000122
从测试结果来看,这些化合物在测试浓度为50μg/mL的条件下对14种常见植物病菌都表现出了离体杀菌活性。对于吡唑酰胺类化合物Ib-2~Ib-9来说,该系列化合物整体对苹果轮纹病菌有较好的抑制活性,大部分化合物的抑制率都在70%以上。化合物Ib-4对辣椒疫霉的抑制率达到80.8%,明显高于商品化的氯苯醚酰胺(51.6%)。化合物Ib-2、Ib-4和Ib-6对小麦纹枯病菌也都表现出了较好的活性,抑制率分别为76.5%、74.5%和62.7%,接近商品化的氯苯醚酰胺(95.8%)。
实施例8:杀虫活性测试,测定程序如下:
粘虫的活性测试
粘虫的实验方法:浸叶法。配置所需浓度后,把直径约为5-6cm的叶片浸入药液中5-6秒,取出,放在吸水纸上晾干,放在指定的培养皿中,接入10头3龄幼虫,放入27±1℃的养虫室中观察3-4天后检查结果。
蚊幼虫的活性测试
蚊幼虫的实验方法:尖音库蚊淡色亚种,室内饲养的正常群体。称取供试化合物约5mg于盘尼西林药瓶中,加5mL丙酮(或适宜溶剂),振荡溶解,即为1000μg/mL母液。移取0.5mL母液,加入盛有89.9mL水的100mL烧杯中,选取10头4龄初蚊子幼虫,连同10mL饲养液一并倒入烧杯中,其药液的浓度即为5μg/mL。放入标准处理室内,24h检查结果。以含有0.5mL实验溶剂的水溶液为空白对照。
棉铃虫的活性测试
棉铃虫的实验方法:浸叶法。配置所需浓度后,把直径约为5-6cm的叶片浸入药液中5-6秒,取出,放在吸水纸上晾干,放在指定的培养皿中,接入10头3龄幼虫,放入27±1℃的养虫室中观察3-4天后检查结果。
玉米螟的活性测试
玉米螟的实验方法:浸叶法,配置后所需浓度后,把直径约为5-6cm的叶片浸入药液中5-6秒,取出,放在吸水纸上晾干,放在指定的培养皿中,接入10头3龄幼虫,放入27±1℃的养虫室中观察3-4天后检查结果。
表2新型吡唑酰胺类化合物Ib-2和Ib-6的杀虫活性测试结果:
Figure BSA0000198333390000131
这两个化合物在初筛浓度下对四种被测昆虫幼虫都表现出了一定的活性。其中,哌嗪N上的取代基为苄基(Ib-6)杀虫活性相对较好。

Claims (5)

1.如下所示结构的新型吡唑酰胺类化合物I,
Figure FSA0000198333380000011
其特征在于通式为以下结构所示的化合物Ia-1~Ia-4,Ib-1~Ib-9
Figure FSA0000198333380000012
Figure FSA0000198333380000021
2.权利要求1中Ia-1~Ia-4的制备方法:使用已商品化的3-(二氟甲基)-1-甲基-1H-吡唑-4-羧酸为原料在氯化亚砜中加热回流制得吡唑酰氯,随后再用吡唑酰氯和相应的Nortopsentin噻唑类衍生物在四丁基硫酸氢铵做相转移催化剂、氢氧化钠做缚酸剂条件下进行酰化反应得到目标化合物Ia-1~Ia-4
Figure FSA0000198333380000022
3.权利要求1中Ib-1~Ib-9的制备方法:使用邻硝基对三氟甲基氟苯与吗啉或单取代的哌嗪进行亲核取代得到相应的中间体a-1~a-9,利用钯碳和氢气体系还原硝基到氨基,最后与吡唑酰氯发生酰化反应得到目标化合物Ib-1~Ib-9,R为结构式Ib-1~Ib-9所示取代基
Figure FSA0000198333380000023
4.权利要求1所述的新型吡唑酰胺类化合物I在防治植物病菌病中的应用,其特征在于它作为抗植物病菌剂,能抑制黄瓜枯萎,花生褐斑,苹果轮纹,小麦纹枯,玉米小斑,西瓜炭疽,水稻恶苗,番茄早疫,小麦赤霉,马铃薯晚疫,辣椒疫霉,油菜菌核,黄瓜灰霉,水稻纹枯14种植物病菌。
5.权利要求1所述的新型吡唑酰胺类化合物Ib-2、Ib-6在防治昆虫中的应用,其特征在于它作为杀虫剂,能抑制粘虫、棉铃虫、玉米螟、蚊幼虫存活。
CN201911344243.6A 2019-12-24 2019-12-24 吡唑酰胺类化合物及其制备和在防治植物病菌病和杀虫中的应用 Active CN113024538B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911344243.6A CN113024538B (zh) 2019-12-24 2019-12-24 吡唑酰胺类化合物及其制备和在防治植物病菌病和杀虫中的应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911344243.6A CN113024538B (zh) 2019-12-24 2019-12-24 吡唑酰胺类化合物及其制备和在防治植物病菌病和杀虫中的应用

Publications (2)

Publication Number Publication Date
CN113024538A true CN113024538A (zh) 2021-06-25
CN113024538B CN113024538B (zh) 2022-09-09

Family

ID=76451469

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911344243.6A Active CN113024538B (zh) 2019-12-24 2019-12-24 吡唑酰胺类化合物及其制备和在防治植物病菌病和杀虫中的应用

Country Status (1)

Country Link
CN (1) CN113024538B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024068950A1 (en) * 2022-09-30 2024-04-04 Syngenta Crop Protection Ag Microbiocidal pyrazole derivatives

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003176273A (ja) * 1999-02-10 2003-06-24 Mitsubishi Pharma Corp アミド化合物およびその医薬としての用途
WO2017147700A1 (en) * 2016-03-01 2017-09-08 Ontario Institute For Cancer Research (Oicr) Inhibitors of wdr5 protein-protein binding
CN108059614A (zh) * 2016-11-09 2018-05-22 沈阳中化农药化工研发有限公司 吡唑酰胺类化合物及其应用
CN109422734A (zh) * 2017-08-21 2019-03-05 南开大学 Nortopsentin类生物碱衍生物及其制备和在防治病虫害中的应用

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003176273A (ja) * 1999-02-10 2003-06-24 Mitsubishi Pharma Corp アミド化合物およびその医薬としての用途
WO2017147700A1 (en) * 2016-03-01 2017-09-08 Ontario Institute For Cancer Research (Oicr) Inhibitors of wdr5 protein-protein binding
CN108059614A (zh) * 2016-11-09 2018-05-22 沈阳中化农药化工研发有限公司 吡唑酰胺类化合物及其应用
CN109422734A (zh) * 2017-08-21 2019-03-05 南开大学 Nortopsentin类生物碱衍生物及其制备和在防治病虫害中的应用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
XI-LE DENG 等: ""Design, synthesis and biological activity of novel substituted pyrazole", 《CHINESE CHEMICAL LETTERS》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024068950A1 (en) * 2022-09-30 2024-04-04 Syngenta Crop Protection Ag Microbiocidal pyrazole derivatives

Also Published As

Publication number Publication date
CN113024538B (zh) 2022-09-09

Similar Documents

Publication Publication Date Title
KR101127785B1 (ko) 콩과식물의 근류형성제로서 유용한 합성 화합물 및 그의제조 방법
CN104961728A (zh) 含吡啶甲氧基联苯基结构的吡唑肟酯类化合物的制备方法和应用
JP3432522B2 (ja) 寄生虫撲減剤のピラゾール
CN113024538B (zh) 吡唑酰胺类化合物及其制备和在防治植物病菌病和杀虫中的应用
US4145428A (en) Fungicidally active 2-acyloxy-1-phenoxy-1-(1,2,4-triazolyl)-3,3-dimethyl-butanes
Yao et al. Design, synthesis and biological evaluation of thiazole and imidazo [1, 2-a] pyridine derivatives containing a hydrazone substructure as potential agrochemicals
CN110759896B (zh) 哌嗪二酮酰腙衍生物及其制备方法和在防治植物病毒、杀菌、杀虫方面的应用
CN113636984A (zh) 一类含吗啉基团的1,3,4-噁二唑类化合物及其制备方法和用途
CN111285814B (zh) 一种含腙结构单元的喹唑啉酮化合物或其立体异构体、或其盐或其溶剂化物
Arnoldi et al. Analogs of phytoalexins. Synthesis of some 3-phenylcoumarins and their fungicidal activity
Zhao et al. Synthesis, fungicidal and insecticidal activity of novel tetronic acid hydrazinyl derivatives
CN110776548A (zh) 一类含异丙醇胺亚结构的乙酰氧基熊果酸哌嗪类化合物及其制备方法和应用
CN112592321B (zh) 一类1,2,3-三氮唑酰肼或酰胺类化合物及其制备方法和应用
EP4223745A1 (en) Dendrene amide compound, bactericide and use thereof
KR840001232B1 (ko) 벤젠아민의 제조방법
CN115260046A (zh) 一种松香酸酯类化合物及其制备方法和应用
CN110759911B (zh) 咔啉衍生物及其制备方法和在防治植物病毒、杀菌、杀虫方面的应用
CN109232534B (zh) 含杂环二芳胺基吡唑甲酰胺类化合物及其制备方法与应用
CN107033134B (zh) 含吡啶盐和1,3,4-噁二唑基的双酰胺类化合物及其制备方法及应用
CN115536543B (zh) 一种含异丙醇胺结构的三氯生类化合物及其制备方法和应用
JPS6026109B2 (ja) 新規1−アシルオキシ−1−フエニル−2−アゾリル−エタンまたはその塩、その製造方法およびそれを活性成分として含有する殺菌剤若しくは殺線虫剤組成物
Luo et al. Synthesis Candidates Herbicide Through Optimization Quinclorac Containing 3-Methyl-1H-pyrazol-5-yl
CN115521306B (zh) 一种1,2,3,4-四氢-β-咔啉衍生物及其制备方法和应用
CN111269237B (zh) 偕二氟化螺-γ-内酰胺吲哚啉化合物及其制备方法和在防治植物病虫害中的应用
CN110272413B (zh) N-噻唑基-1-吡啶基-5-吡唑甲酰胺衍生物及其应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant